Testing effectiveness (Phase 2)UnknownNCT05763992
What this trial is testing
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Who this might be right for
Breast CancerTriple Negative Breast CancerDietary Exposure+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 145